A pH stimuli thiol modified mesoporous silica nanoparticles: Doxorubicin carrier for cancer therapy
This study attested that pH-responsive thiol modified drug nanocarrier can have the potential cancer therapy. Graphical abstract
Source: Journal of the Taiwan Institute of Chemical Engineers - Category: Chemistry Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemistry | Chia | Nanotechnology | PET Scan | Study | Taiwan Health